Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Rheopheresis as Adjuvant Treatment of Calciphylaxis in Hemodialysis Patients : a Prospective Randomized Controled Single-blind Trial

NCT04654000 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04654000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04654000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Rheopheresis as Adjuvant Treatment of Calciphylaxis in Hemodialysis Patients : a Prospective Randomized Controled Single-blind Trial
Lead sponsor
University Hospital, Lille
Phase
Not applicable
Overall status
Recruiting
Start date
March 7, 2023
Completion date
May 31, 2027
Enrollment
138 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, metabolic disorder, rare diseases